Evofem shares surge as contraceptive gel meets late-stage trial goal

Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel showed effectiveness in a late-stage study, bringing the first hormone-free contraceptive close to approval.


from Reuters: Health News https://ift.tt/2PHRi7p

No comments:

Post a Comment

Teen struggling w/ weight + no support at home, where the hell do I even start?

So I’m a teenager and I’ve been overweight/obese basically my whole life. And it’s been messing with me pretty bad. For the record, I don’...